RxDoctor Payments Data

Matt Mors, DO

Otolaryngology/Facial Plastic Surgery · Boise, IDNPI 1871904698

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 33 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 16.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $324 and has fallen 50.1% since, to $162 in 2025.

$761in general payments, 2019–2025

Across 33 payments — averaging $23.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Aerin Medical Inc.$127
  • Medtronic$106
  • Novo Nordisk$64
  • Exact Sciences$43
  • Amgen$36
  • Dexcom, Inc.$34
  • plus $353 from 19 others

What the payments were for

  • Food & beverage$761100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few otolaryngology/facial plastic surgery providers in Idahoto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$56,710
Medicare patients
175
Services billed
399

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ipratropium Bromide94$2,119
Azelastine Hcl36$1,287
Fluticasone Propionate77$1,134
Famotidine56$480
Omeprazole62$448
Doxycycline Monohydrate20$412
Nortriptyline Hcl33$363
Indapamide22$297
Ciprofloxacin Hcl15$297
Mupirocin42$282
Fluconazole17$223
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav23$211
Montelukast Sodium16$195
Sertraline Hcl38$129
Ondansetron OdtOndansetron19$99

Paid to pharmacies, not to this prescriber.

Other otolaryngology/facial plastic surgery in Boise

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →